Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
15.61
+0.65 (4.34%)
At close: Jan 3, 2025, 4:00 PM
15.63
+0.02 (0.13%)
Pre-market: Jan 6, 2025, 8:08 AM EST
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CAPR stock have an average target of 39.29, with a low estimate of 25 and a high estimate of 77. The average target predicts an increase of 151.70% from the current stock price of 15.61.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CAPR stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 4 | 4 | 4 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +393.27% | Jan 2, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +156.25% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +393.27% | Nov 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $25 → $30 | Buy | Maintains | $25 → $30 | +92.18% | Nov 14, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $35 | Buy | Initiates | $35 | +124.22% | Oct 21, 2024 |
Financial Forecast
Revenue This Year
17.11M
from 25.18M
Decreased by -32.05%
Revenue Next Year
29.92M
from 17.11M
Increased by 74.85%
EPS This Year
-1.32
from -0.83
EPS Next Year
-1.03
from -1.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 32.6M | 150.7M | 170.5M | |||
| Avg | 17.1M | 29.9M | 103.7M | |||
| Low | 10.9M | n/a | 39.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 29.3% | 780.7% | 470.0% | |||
| Avg | -32.0% | 74.8% | 246.7% | |||
| Low | -56.6% | - | 31.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.86 | 1.64 | 1.71 | |||
| Avg | -1.32 | -1.03 | 0.41 | |||
| Low | -1.42 | -1.63 | -1.18 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.